Literature DB >> 29331223

Structure-based design and application of a nucleotide coenzyme mimetic ligand: Application to the affinity purification of nucleotide dependent enzymes.

Marigianna Marinou1, Dimitrios Platis1, Farid S Ataya2, Evangelia Chronopoulou1, Dimitrios Vlachakis3, Nikolaos E Labrou4.   

Abstract

In the present study, a structure-based approach was exploited for the in silico design of a nucleotide coenzyme mimetic ligand. The enzyme formate dehydrogenase (FDH) was employed as a model in our study. The biomimetic ligand was designed and synthesized based on a tryptamine/3-aminopropylphosphonic acid bi-substituted 1,3,5-triazine (Trz) scaffold (Tra-Trz-3APP), which potentially mimics the interactions of NAD+-FDH complex. Molecular docking studies of the biomimetic ligand predicted that it can occupy the same binding site as the natural coenzyme. Molecular modeling and dynamics simulations revealed that the ligand binds in an energetically more stable pose in the FDH binding site, as it adopts a more twisty conformation, compared to the natural coenzyme. Study of the FDH/Tra-Trz-3APP-Sepharose interaction, through adsorption equilibrium studies and site-directed mutagenesis of selected FDH coenzyme binding residues, provided additional experimental evidences of the specificity of the interaction. The Tra-Trz-3APP-Sepharose biomimetic adsorbent was further evaluated towards a range of different dehydrogenases and was exploited for the development of a single-step purification protocol for FDH. The protocol afforded enzyme with high yield and purity, suitable for analytical and industrial purposes.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Affinity chromatography; Formate dehydrogenase; Ligand design; Site-directed mutagenesis; Structural bioinformatics

Mesh:

Substances:

Year:  2018        PMID: 29331223     DOI: 10.1016/j.chroma.2018.01.009

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  7 in total

1.  Multiple Target Drug Design Using LigBuilder 3.

Authors:  Xiaoyu Qing; Shiwei Wang; Yaxia Yuan; Jianfeng Pei; Luhua Lai
Journal:  Methods Mol Biol       Date:  2021

Review 2.  Microbiome Hijacking Towards an Integrative Pest Management Pipeline.

Authors:  Vasiliki Lila Koumandou; Louis Papageorgiou; Spyridon Champeris Tsaniras; Aegli Papathanassopoulou; Marianna Hagidimitriou; Nikos Cosmidis; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

3.  Antibody Clustering Using a Machine Learning Pipeline that Fuses Genetic, Structural, and Physicochemical Properties.

Authors:  Louis Papageorgiou; Dimitris Maroulis; George P Chrousos; Elias Eliopoulos; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

4.  Drugena: A Fully Automated Immunoinformatics Platform for the Design of Antibody-Drug Conjugates Against Neurodegenerative Diseases.

Authors:  Louis Papageorgiou; Eleni Papakonstantinou; Constantinos Salis; Eleytheria Polychronidou; Marianna Hagidimitriou; Dimitris Maroulis; Elias Eliopoulos; Dimitrios Vlachakis
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

5.  Reduce, Reuse and Recycle in Protein Chromatography: Development of an Affinity Adsorbent from Waste Paper and Its Application for the Purification of Proteases from Fish By-Products.

Authors:  Georgios E Premetis; Nikolaos E Labrou
Journal:  Biomolecules       Date:  2020-05-27

6.  Probing the Role of the Conserved Arg174 in Formate Dehydrogenase by Chemical Modification and Site-Directed Mutagenesis.

Authors:  Mohammed Hamed Alqarni; Ahmed Ibrahim Foudah; Magdy Mohamed Muharram; Haritium Budurian; Nikolaos E Labrou
Journal:  Molecules       Date:  2021-02-25       Impact factor: 4.411

Review 7.  Epitranscriptomics of cardiovascular diseases (Review).

Authors:  Stefanos Leptidis; Eleni Papakonstantinou; Kalliopi Io Diakou; Katerina Pierouli; Thanasis Mitsis; Konstantina Dragoumani; Flora Bacopoulou; Despina Sanoudou; George P Chrousos; Dimitrios Vlachakis
Journal:  Int J Mol Med       Date:  2021-11-18       Impact factor: 4.101

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.